Neck ultrasound for hidden artery disease in diabetes with kidney disease
Part of Heart & circulation, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial uses a simple neck ultrasound (carotid Doppler) to check for early signs of blocked arteries in people with type 2 diabetes and moderate kidney disease. It aims to catch heart risks early so they can be treated sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 2 diabetes.
- You have chronic kidney disease stage 3 (kidney function 30-59 for at least 3 months).
- You have been stable, with no sudden kidney problems or heart-related hospital stay in the last 3 months.
- You are willing and able to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how blood vessels behave in people with kidney disease or at risk for it. Researchers will use special sensors to understand how vessel stiffness changes, which could help predict and prevent heart and kidney problems.
This study uses a neck ultrasound to look at the texture of your carotid artery (a main blood vessel in your neck) to find early signs of heart and blood vessel risk. It is for adults with type 2 diabetes who have not already had a heart attack or stroke.
This study looks at whether an ultrasound of the carotid artery (the main artery in your neck) can help predict drops in blood pressure during dialysis. It may help doctors find people at risk for low blood pressure during treatment.
This study uses a special ultrasound to look for early signs of artery changes in people with prediabetes. The goal is to find out how prediabetes affects arteries before any symptoms appear.
This study uses special kidney imaging to look for patterns that can predict how diabetic kidney disease may progress. It may help researchers find better ways to identify people at higher risk using noninvasive (and possibly biopsy-related) tests.
This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.